Suppr超能文献

有格雷夫斯病家族史的甲状腺功能正常受试者对促甲状腺激素释放激素(TRH)和三碘甲状腺原氨酸(T3)抑制试验的反应。

Responses to TRH and T3 suppression tests in euthyroid subjects with a family history of Graves' disease.

作者信息

Tamai H, Suematsu H, Ikemi Y, Kuma K, Matsuzuka F, Kumagai L F, Shizume K, Nagataki S

出版信息

J Clin Endocrinol Metab. 1978 Sep;47(3):475-9. doi: 10.1210/jcem-47-3-475.

Abstract

The relationship of Graves' disease and heredity was studied in 97 clinically and biochemically euthyroid relatives (resin T3 uptake and serum T3, T4, and TSH within normal ranges) who had more than two thyrotoxic relatives within the second degree relationship. TRH tests were preformed in all 97 cases. In 56 of the 97, T3 suppression tests were performed shortly after the TRH test. Results revealed that 29 of the 97 (29.9%) showed an abnormal response to TRH. fourteen of these (14.4%) revealed no response or a hyporesponse, and 15 (15.5%) revealed a hyperresponse to TRH. Four of 56 (7.1%) were T3 nonsuppressible. Seven individuals who showed no response or a hyporesponse to TRH consisted of 2 nonsuppressible and 5 suppressible subjects. In 14 non- or hyporesponsive cases, serum T3 (1.51 +/- 0.05 ng/ml; mean +/- SE) and T4 (9.91 +/- 0.31 micrograms/dl) were significantly higher compared with those of normal responders (1.30 +/- 0.04 ng/ml, 8.57 +/- 0.21 micrograms/dl; P less than 0.001) or hyperresponders (1.16 +/- 0.06 ng/ml, 7.77 +/- 0.63 micrograms/dl; P less than 0.01). There was no correlation between TRH responsiveness and T3 suppressibility. A relatively high occurrence of thyroglobulin and microsomal antibodies was observed, further suggesting a hereditary predisposition. The findings indicate that even in euthyroid relatives with a family history of Graves' disease who have no clinical or biochemical abnormalities of thyroid dysfunction, many have abnormalities in TRH responsiveness, T3 suppressibility, and thyroidal antibodies.

摘要

对97名临床及生化检查甲状腺功能正常的亲属(树脂T3摄取率以及血清T3、T4和TSH在正常范围内)进行了研究,这些亲属在二级亲属关系中有两个以上甲状腺毒症亲属。对所有97例均进行了促甲状腺激素释放激素(TRH)试验。其中56例在TRH试验后不久进行了T3抑制试验。结果显示,97例中有29例(29.9%)对TRH反应异常。其中14例(14.4%)无反应或低反应,15例(15.5%)对TRH高反应。56例中有4例(7.1%)T3不能被抑制。对TRH无反应或低反应的7例个体中,2例T3不能被抑制,5例T3可被抑制。在14例无反应或低反应的病例中,血清T3(1.51±0.05 ng/ml;均值±标准误)和T4(9.91±0.31μg/dl)显著高于正常反应者(1.30±0.04 ng/ml,8.57±0.21μg/dl;P<0.001)或高反应者(1.16±0.06 ng/ml,7.77±0.63μg/dl;P<0.01)。TRH反应性与T3抑制性之间无相关性。观察到甲状腺球蛋白和微粒体抗体的发生率相对较高,进一步提示存在遗传易感性。这些发现表明,即使是甲状腺功能正常且有格雷夫斯病家族史、无甲状腺功能障碍临床或生化异常的亲属,许多人在TRH反应性、T3抑制性和甲状腺抗体方面也存在异常。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验